OUR MISSION
We want to push the boundaries of rehabilitation, by delivering personalized, effective, and accessible solutions that empower individuals to thrive in their daily lives.
OUR VISION
A world where cutting-edge rehabilitation is universally available, unleashing human potential beyond physical limitations.
Our Story
Rehabilia Technologies was born out of our desire to bring our passion for technology to the service of people with disabilities, and in particular children.
After many years of experience in national and international research activities, we decided to apply the results of our research to the development of solutions that can have a significant impact on people’s health.
Rehabilia Technologies emerged as a spin-off of the National Research Council of Italy (CNR), reflecting a seamless transition from research to innovation, in late May 2023. The company’s establishment followed a path of innovation and dedication to advancing the field of neuromotor rehabilitation.

Awards and recognitions

30,000€ prize by the Bio4Dreams incubator at Premio 2031.

Mentorship program Challenge Smart-Therapy in Rehabilitation by the Smart & Touch-ID HUB.

LBG Innovator’s Road Program, securing one of the ten coveted spots in 2022.

One of the ten European projects selected by the EIT Health MedTech BootCamp 2022.

InnovUp SUB2022 Special Award at the Meet In Italy For Life Sciences Startup Breeding 2022.

One of the 12 Top Medical Start-ups 2022 at Medica 2022.

25,000€ Social Impact Award at StartCup Lombardia 2022.

One of the top seven finalists within the 2023 EIT Health Wild Card program.

Finalist at the 2023 Switch2Product Innovation Challenge and participation to the Polihub’s S2P Acceleration Program 2023-2024.
The Team

Matteo
Malosio
Chief Executive Officer
Co-Founder

Matteo
Lavit Nicora
Chief Technology Officer
Co-Founder

Giovanni
Tauro
Chief Product Officer
Co-Founder

Francesca
Fedeli
Patient & Family
Advisor

Giuseppina
Sgandurra
Medical
Advisor

Marco
Lodi Pasini
Clinical
Advisor

Elena
Beani
Clinical
Advisor

Werner
Wutscher
Business
Advisor

Gianluca
Sferrazza
Regulatory Affairs
Advisor